Venetoclax induces deep hematologic remissions in t(11;14) relapsed/refractory AL amyloidosis.
- DOI
- 10.1038/s41408-020-00397-w
- Published
- 2021-01-11
- Container
- Blood Cancer J
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- supportingDirectory of Open Access Journals: A matching record was returned by DOAJ.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1038/s41408-020-00397-w,
title = {Venetoclax induces deep hematologic remissions in t(11;14) relapsed/refractory AL amyloidosis.},
author = {Premkumar VJ and Lentzsch S and Pan S and Bhutani D and Richter J and Jagannath S and Liedtke M and Jaccard A and Wechalekar AD and Comenzo R and Sanchorawala V and Royer B and Rosenzweig M and Valent J and Schönland S and Fonseca R and Wong S and Kapoor P.},
year = {2021},
journal = {Blood Cancer J},
doi = {10.1038/s41408-020-00397-w},
url = {https://doi.org/10.1038/s41408-020-00397-w}
}RIS
TY - JOUR TI - Venetoclax induces deep hematologic remissions in t(11;14) relapsed/refractory AL amyloidosis. AU - Premkumar VJ AU - Lentzsch S AU - Pan S AU - Bhutani D AU - Richter J AU - Jagannath S AU - Liedtke M AU - Jaccard A AU - Wechalekar AD AU - Comenzo R AU - Sanchorawala V AU - Royer B AU - Rosenzweig M AU - Valent J AU - Schönland S AU - Fonseca R AU - Wong S AU - Kapoor P. PY - 2021 JO - Blood Cancer J DO - 10.1038/s41408-020-00397-w UR - https://doi.org/10.1038/s41408-020-00397-w ER -
APA
VJ, P., S, L., S, P., D, B., J, R., S, J., M, L., A, J., AD, W., R, C., V, S., B, R., M, R., J, V., S, S., R, F., S, W., & P., K. (2021). Venetoclax induces deep hematologic remissions in t(11;14) relapsed/refractory AL amyloidosis.. Blood Cancer J. https://doi.org/10.1038/s41408-020-00397-w
Source records
- europe-pmc · retrieved 2026-09-26T01:09:49.163Z
- doaj · retrieved 2026-09-26T01:09:49.193Z